HiFiBiO Therapeutics Overview

  • Founded

  • 2013

Founded
  • Status

  • Private

  • Employees

  • 74

Employees
  • Latest Deal Type

  • Series D

  • Latest Deal Amount

  • $75M

  • Investors

  • 21

HiFiBiO Therapeutics General Information

Description

Developer of a single-cell analytics platform designed to mobilize the human immune system to combat cancer and autoimmune disorders. The company's platform integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibodies, enabling doctors to unlock the curative powers of the immune system with innovative biotherapeutics.

Contact Information

Website
www.hifibio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 237 Putnam Avenue
  • Cambridge, MA 02139
  • United States

HiFiBiO Therapeutics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HiFiBiO Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series D) 01-Jun-2021 $75M 00000 Completed Generating Revenue
4. Debt - PPP 27-Apr-2020 00000 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 28-Aug-2019 0000 00000 Completed Generating Revenue
2. Later Stage VC (Series B) 16-May-2018 $37.5M $41.7M Completed Generating Revenue
1. Early Stage VC (Series A) 27-Jan-2017 $4.21M $4.21M 000.00 Completed Generating Revenue
To view HiFiBiO Therapeutics’s complete valuation and funding history, request access »

HiFiBiO Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
P 000,000 00.000000 00.00 00.00 00 00.00 00.000
P 000,000 00.000000 00.00 00.00 00 00.00 0.000
P 195,089 $0.010609 $10.31 $10.31 1x $10.31 12.87%
Ordinary 1,000,000 $0.010609
To view HiFiBiO Therapeutics’s complete cap table history, request access »

HiFiBiO Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a single-cell analytics platform designed to mobilize the human immune system to combat cancer and autoimmu
Drug Discovery
Cambridge, MA
74 As of 2023
00000
00000000000 00000

000000

ctetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000

000000

olor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pari
0000 000000000
San Carlos, CA
00 As of 0000
00000
000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HiFiBiO Therapeutics Competitors (53)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytomX Therapeutics Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 Formerly VC-backed San Carlos, CA 00 00000 000000&0 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 0000000000.
00000000 000000000 Venture Capital-Backed Uppsala, Sweden 00 0000000000
00000 00000000 Formerly VC-backed Cambridge, MA 00 00000 0000 00000
You’re viewing 5 of 53 competitors. Get the full list »

HiFiBiO Therapeutics Patents

  • 74

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 13

    Pending

  • 000

    Expiring in next 12 mo

HiFiBiO Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021296366-A1 Methods for identification of cognate pairs of ligands and receptors Pending 24-Jun-2020 0000000000
CA-3183029-A1 Methods for identification of cognate pairs of ligands and receptors Pending 24-Jun-2020 0000000000
EP-4172627-A1 Methods for identification of cognate pairs of ligands and receptors Pending 24-Jun-2020 0000000000
EP-4168435-A1 Predictive response biomarker discovery process Pending 19-Jun-2020 0000000000
US-20230160009-A1 Predictive response biomarker discovery process Pending 19-Jun-2020 C12Q1/6881
To view HiFiBiO Therapeutics’s complete patent history, request access »

HiFiBiO Therapeutics Executive Team (17)

Name Title Board Seat Contact Info
Liang Schweizer Ph.D Co-Founder, Chief Executive Officer, President & Chairman
Jeff He Co-Founder & Chief Operating Officer
Francisco Adrian Ph.D Chief Scientific Officer & Vice President
Rachel Yao Finance Controller
Jerome Bibette Ph.D Scientific Co-Founder
You’re viewing 5 of 17 executive team members. Get the full list »

HiFiBiO Therapeutics Board Members (3)

Name Representing Role Since
Robert Nicol Ph.D Self Scientific Co-Founder 000 0000
Seung Wook Jeong Mirae Asset Global Investments Board Member 000 0000
Tiger Hu MD IDG Capital Board Member 000 0000
To view HiFiBiO Therapeutics’s complete board members history, request access »

HiFiBiO Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HiFiBiO Therapeutics Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
B Capital Group Venture Capital Minority 000 0000 000000 0
Fong Capital Partners Growth/Expansion Minority 000 0000 000000 0
Further Global Capital Management PE/Buyout Minority 000 0000 000000 0
Grand Mount Capital Venture Capital Minority 000 0000 000000 0
Hengxu Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

HiFiBiO Therapeutics Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 10-Dec-2018 00000 0000 Biotechnology 00000 000
H-Immune Therapeutics 15-Oct-2018 Merger/Acquisition Drug Discovery 00000 000
To view HiFiBiO Therapeutics’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial